These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 31050209)

  • 21. Significant nailfold capillary loss and late capillaroscopic pattern are associated with pulmonary arterial hypertension in systemic sclerosis.
    De Angelis R; Riccieri V; Cipolletta E; Del Papa N; Ingegnoli F; Bosello S; Spinella A; Pellegrino G; de Pinto M; Papa S; Armentaro G; Giuggioli D
    Rheumatology (Oxford); 2024 May; 63(6):1616-1623. PubMed ID: 37624917
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of the 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis (SSc) in large, well-defined cohorts of SSc and mixed connective tissue disease.
    Hoffmann-Vold AM; Gunnarsson R; Garen T; Midtvedt Ø; Molberg Ø
    J Rheumatol; 2015 Jan; 42(1):60-3. PubMed ID: 25274890
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal Nailfold Capillaroscopy Is Common in Patients with Connective Tissue Disease and Associated with Abnormal Pulmonary Function Tests.
    van Roon AM; Huisman CC; van Roon AM; Zhang D; Stel AJ; Smit AJ; Bootsma H; Mulder DJ
    J Rheumatol; 2019 Sep; 46(9):1109-1116. PubMed ID: 30554151
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
    Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is there an association between glaucoma and capillaroscopy in patients with systemic sclerosis?
    Gomes BF; Souza R; Valadão T; Kara-Junior N; Moraes HV; Santhiago MR
    Int Ophthalmol; 2018 Feb; 38(1):251-256. PubMed ID: 28478533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. From VEDOSS to established systemic sclerosis diagnosis according to ACR/EULAR 2013 classification criteria: a French-Italian capillaroscopic survey.
    Vasile M; Avouac J; Sciarra I; Stefanantoni K; Iannace N; Cravotto E; Valesini G; Allanore Y; Riccieri V
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):82-87. PubMed ID: 30183599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SSc.
    Bellocchi C; Assassi S; Lyons M; Marchini M; Mohan C; Santaniello A; Beretta L
    Arthritis Res Ther; 2023 Jan; 25(1):15. PubMed ID: 36707842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between nailfold capillaroscopic assessment and telangiectasia score with severity of peripheral vascular involvement in systemic sclerosis.
    Yalcinkaya Y; Pehlivan O; Omma A; Alpay N; Erer B; Kamali S; Ocal L; Inanc M
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S92-7. PubMed ID: 25797836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microvascular abnormalities in patients with early systemic sclerosis: less severe morphological changes than in patients with definite disease.
    Camargo CZ; Sekiyama JY; Arismendi MI; Kayser C
    Scand J Rheumatol; 2015; 44(1):48-55. PubMed ID: 25379977
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticentromere Antibody Levels and Isotypes and the Development of Systemic Sclerosis.
    van Leeuwen NM; Boonstra M; Bakker JA; Grummels A; Jordan S; Liem S; Distler O; Hoffmann-Vold AM; Melsens K; Smith V; Truchetet ME; Scherer HU; Toes R; Huizinga TWJ; de Vries-Bouwstra JK
    Arthritis Rheumatol; 2021 Dec; 73(12):2338-2347. PubMed ID: 34042326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sequential nailfold videocapillaroscopy examinations have responsiveness to detect organ progression in systemic sclerosis.
    Avouac J; Lepri G; Smith V; Toniolo E; Hurabielle C; Vallet A; Amrouche F; Kahan A; Cutolo M; Allanore Y
    Semin Arthritis Rheum; 2017 Aug; 47(1):86-94. PubMed ID: 28291582
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study.
    Ingegnoli F; Boracchi P; Gualtierotti R; Smith V; Cutolo M; Foeldvari I;
    Microvasc Res; 2015 Nov; 102():19-24. PubMed ID: 26254260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS).
    Bellando-Randone S; Del Galdo F; Lepri G; Minier T; Huscher D; Furst DE; Allanore Y; Distler O; Czirják L; Bruni C; Guiducci S; Avouac J; Cutolo M; Smith V; Matucci-Cerinic M;
    Lancet Rheumatol; 2021 Dec; 3(12):e834-e843. PubMed ID: 38287630
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Capillary loss on nailfold capillary microscopy is associated with mortality in systemic sclerosis.
    Pavan TR; Bredemeier M; Hax V; Capobianco KG; da Silva Mendonça Chakr R; Xavier RM
    Clin Rheumatol; 2018 Feb; 37(2):475-481. PubMed ID: 29018976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hit hard and early: analysing the effects of high-dose methylprednisolone on nailfold capillary changes and biomarkers in very early systemic sclerosis: study protocol for a 12-week randomised controlled trial.
    van den Hombergh WMT; Kersten BE; Knaapen-Hans HKA; Thurlings RM; van der Kraan PM; van den Hoogen FHJ; Fransen J; Vonk MC
    Trials; 2018 Aug; 19(1):449. PubMed ID: 30134971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Automated structure and flow measurement - a promising tool in nailfold capillaroscopy.
    Berks M; Dinsdale G; Murray A; Moore T; Manning J; Taylor C; Herrick AL
    Microvasc Res; 2018 Jul; 118():173-177. PubMed ID: 29605552
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of Systemic Sclerosis in Primary Biliary Cholangitis Using the New ACR/EULAR Classification Criteria.
    Zheng B; Vincent C; Fritzler MJ; Senécal JL; Koenig M; Joyal F
    J Rheumatol; 2017 Jan; 44(1):33-39. PubMed ID: 27744398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The emerging application of semi-quantitative and quantitative capillaroscopy in systemic sclerosis.
    Mihai C; Smith V; Dobrota R; Gheorghiu AM; Cutolo M; Distler O
    Microvasc Res; 2018 Jul; 118():113-120. PubMed ID: 29544760
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Microvascular damage evaluation in systemic sclerosis: the role of nailfold videocapillaroscopy and laser techniques.
    Ruaro B; Sulli A; Smith V; Pizzorni C; Paolino S; Alessandri E; Cutolo M
    Reumatismo; 2017 Dec; 69(4):147-155. PubMed ID: 29320840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential performance of nailfold video capillaroscopic parameters in the diagnosis and prognosis of systemic sclerosis.
    Bournia VK; Kottas K; Panopoulos S; Konstantonis G; Iliopoulos A; Tektonidou MG; Tzioufas AG; Sfikakis PP; Vlachoyiannopoulos PG
    Clin Exp Rheumatol; 2020; 38 Suppl 125(3):29-39. PubMed ID: 31969216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.